Featured Articles
Latest Articles
Article
Navigating GDPR Guidelines in Decentralized Trials
This article explores how sponsors can overcome some of the challenges of data privacy when conducting decentralized clinical trials.
Article
Excelling at Accelerating in Rare Disease Drug Development
In this article, we discuss several challenges in rare disease drug development and why the need for innovation in this space is even more critical than for more common diseases.
Article
Molecular Science and Art With Professor David Goodsell
Technology Networks interviews renowned structural biologist-turned molecular artist, Professor David Goodsell.
Article
Egg on Our Face: Another Asilomar Moment?
Michael Kinch confronts a recent controversy in the field of immunology, where researchers failed to seek permission or guidance from the NIAID before engineering mutant forms of SARS-CoV-2.
Article
Millions in FDA Fines and Thousands of Warning Letters: How GxP Compliance Software Can Help Avoid Them
In this article, we explore the benefits of adopting a single GxP software solution across all sites.
Article
Redesigning Medicine Using Synthetic Biology
This article will discuss how synthetic biology can be exploited to explore mechanisms of human disease, as well as develop treatments, highlighting key examples.
Article
Top Science News Stories of 2022
As the year ends, it’s time to reflect on the stories that you enjoyed the most. Here’s our roundup of this year’s most popular headlines, including new findings on how we humans age, the impact of diet on the microbiome and a revelation on the cause of multiple sclerosis (MS).
Article
Quality Control During Drug Development
This article discusses the importance of quality control during drug development and highlights techniques used to confirm the identity and purity of pharmaceutical products.
Article
Measuring Potency of Cell and Gene Therapy Products
This article highlights the importance of measuring potency for cell and gene therapies.
Article
Making Cancer Medicines With Microbes
For oncology, plant-based anti-cancer drugs have proven instrumental in the fight against a disease that claims approximately 609,360 lives in the United States alone. But their demand far outweighs their supply. Can yeast help?
Advertisement